Global C-X-C Chemokine Receptor Type 4 Market Insights and Forecast to 2026

世界のC-X-Cケモカイン受容体タイプ4市場2026:インサイト・予測

◆タイトル:Global C-X-C Chemokine Receptor Type 4 Market Insights and Forecast to 2026
◆商品コード:QYR20NV00812
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:149
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥672,750見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートはC-X-Cケモカイン受容体タイプ4の世界市場について調査・分析した資料です。種類別(AM-3114、BL-8040、GMI-1359、HPH-112、その他)の市場規模、用途別(肝がん、心筋梗塞、腎細胞がん、脳卒中、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別C-X-Cケモカイン受容体タイプ4の競争状況、市場シェア
・世界のC-X-Cケモカイン受容体タイプ4市場:種類別市場規模 2015年-2020年(AM-3114、BL-8040、GMI-1359、HPH-112、その他)
・世界のC-X-Cケモカイン受容体タイプ4市場:種類別市場規模予測 2021年-2026年(AM-3114、BL-8040、GMI-1359、HPH-112、その他)
・世界のC-X-Cケモカイン受容体タイプ4市場:用途別市場規模 2015年-2020年(肝がん、心筋梗塞、腎細胞がん、脳卒中、その他)
・世界のC-X-Cケモカイン受容体タイプ4市場:用途別市場規模予測 2021年-2026年(肝がん、心筋梗塞、腎細胞がん、脳卒中、その他)
・北米のC-X-Cケモカイン受容体タイプ4市場分析:米国、カナダ
・ヨーロッパのC-X-Cケモカイン受容体タイプ4市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのC-X-Cケモカイン受容体タイプ4市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のC-X-Cケモカイン受容体タイプ4市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのC-X-Cケモカイン受容体タイプ4市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):AdAlta Pty Ltd.、Ambrx, Inc.、Anchor Therapeutics, Inc.、Biokine Therapeutics Ltd.、BioLineRx, Ltd.、Bristol-Myers Squibb Company、Eli Lilly and Company、Globavir Biosciences, Inc.、GlycoMimetics, Inc.、NeED Pharma s.r.l.、Pharis Biotec GmbH、Polyphor Ltd.、Sanofi、TaiGen Biotechnology Co., Ltd.、Upsher-Smith Laboratories, Inc.、X4 Pharmaceuticals, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global C-X-C Chemokine Receptor Type 4 Market
The global C-X-C Chemokine Receptor Type 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global C-X-C Chemokine Receptor Type 4 Scope and Market Size
C-X-C Chemokine Receptor Type 4 market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global C-X-C Chemokine Receptor Type 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the C-X-C Chemokine Receptor Type 4 market is segmented into
AM-3114
BL-8040
GMI-1359
HPH-112
Others

Segment by Application, the C-X-C Chemokine Receptor Type 4 market is segmented into
Liver Cancer
Myocardial Infarction
Renal Cell Carcinoma
Stroke
Others

Regional and Country-level Analysis
The C-X-C Chemokine Receptor Type 4 market is analysed and market size information is provided by regions (countries).
The key regions covered in the C-X-C Chemokine Receptor Type 4 market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and C-X-C Chemokine Receptor Type 4 Market Share Analysis
C-X-C Chemokine Receptor Type 4 market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in C-X-C Chemokine Receptor Type 4 business, the date to enter into the C-X-C Chemokine Receptor Type 4 market, C-X-C Chemokine Receptor Type 4 product introduction, recent developments, etc.

The major vendors covered:
AdAlta Pty Ltd.
Ambrx, Inc.
Anchor Therapeutics, Inc.
Biokine Therapeutics Ltd.
BioLineRx, Ltd.
Bristol-Myers Squibb Company
Eli Lilly and Company
Globavir Biosciences, Inc.
GlycoMimetics, Inc.
NeED Pharma s.r.l.
Pharis Biotec GmbH
Polyphor Ltd.
Sanofi
TaiGen Biotechnology Co., Ltd.
Upsher-Smith Laboratories, Inc.
X4 Pharmaceuticals, Inc.

【レポートの目次】

1 Study Coverage
1.1 C-X-C Chemokine Receptor Type 4 Product Introduction
1.2 Market Segments
1.3 Key C-X-C Chemokine Receptor Type 4 Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type
1.4.2 AM-3114
1.4.3 BL-8040
1.4.4 GMI-1359
1.4.5 HPH-112
1.4.6 Others
1.5 Market by Application
1.5.1 Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Application
1.5.2 Liver Cancer
1.5.3 Myocardial Infarction
1.5.4 Renal Cell Carcinoma
1.5.5 Stroke
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global C-X-C Chemokine Receptor Type 4 Market Size, Estimates and Forecasts
2.1.1 Global C-X-C Chemokine Receptor Type 4 Revenue 2015-2026
2.1.2 Global C-X-C Chemokine Receptor Type 4 Sales 2015-2026
2.2 Global C-X-C Chemokine Receptor Type 4, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global C-X-C Chemokine Receptor Type 4 Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global C-X-C Chemokine Receptor Type 4 Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global C-X-C Chemokine Receptor Type 4 Competitor Landscape by Players
3.1 C-X-C Chemokine Receptor Type 4 Sales by Manufacturers
3.1.1 C-X-C Chemokine Receptor Type 4 Sales by Manufacturers (2015-2020)
3.1.2 C-X-C Chemokine Receptor Type 4 Sales Market Share by Manufacturers (2015-2020)
3.2 C-X-C Chemokine Receptor Type 4 Revenue by Manufacturers
3.2.1 C-X-C Chemokine Receptor Type 4 Revenue by Manufacturers (2015-2020)
3.2.2 C-X-C Chemokine Receptor Type 4 Revenue Share by Manufacturers (2015-2020)
3.2.3 Global C-X-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by C-X-C Chemokine Receptor Type 4 Revenue in 2019
3.2.5 Global C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 C-X-C Chemokine Receptor Type 4 Price by Manufacturers
3.4 C-X-C Chemokine Receptor Type 4 Manufacturing Base Distribution, Product Types
3.4.1 C-X-C Chemokine Receptor Type 4 Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C-X-C Chemokine Receptor Type 4 Product Type
3.4.3 Date of International Manufacturers Enter into C-X-C Chemokine Receptor Type 4 Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global C-X-C Chemokine Receptor Type 4 Market Size by Type (2015-2020)
4.1.1 Global C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020)
4.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue by Type (2015-2020)
4.1.3 C-X-C Chemokine Receptor Type 4 Average Selling Price (ASP) by Type (2015-2026)
4.2 Global C-X-C Chemokine Receptor Type 4 Market Size Forecast by Type (2021-2026)
4.2.1 Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Type (2021-2026)
4.2.2 Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Type (2021-2026)
4.2.3 C-X-C Chemokine Receptor Type 4 Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global C-X-C Chemokine Receptor Type 4 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global C-X-C Chemokine Receptor Type 4 Market Size by Application (2015-2020)
5.1.1 Global C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020)
5.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue by Application (2015-2020)
5.1.3 C-X-C Chemokine Receptor Type 4 Price by Application (2015-2020)
5.2 C-X-C Chemokine Receptor Type 4 Market Size Forecast by Application (2021-2026)
5.2.1 Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Application (2021-2026)
5.2.2 Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Application (2021-2026)
5.2.3 Global C-X-C Chemokine Receptor Type 4 Price Forecast by Application (2021-2026)

6 North America
6.1 North America C-X-C Chemokine Receptor Type 4 by Country
6.1.1 North America C-X-C Chemokine Receptor Type 4 Sales by Country
6.1.2 North America C-X-C Chemokine Receptor Type 4 Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Type
6.3 North America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Application

7 Europe
7.1 Europe C-X-C Chemokine Receptor Type 4 by Country
7.1.1 Europe C-X-C Chemokine Receptor Type 4 Sales by Country
7.1.2 Europe C-X-C Chemokine Receptor Type 4 Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Type
7.3 Europe C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific C-X-C Chemokine Receptor Type 4 by Region
8.1.1 Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Region
8.1.2 Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Type
8.3 Asia Pacific C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Application

9 Latin America
9.1 Latin America C-X-C Chemokine Receptor Type 4 by Country
9.1.1 Latin America C-X-C Chemokine Receptor Type 4 Sales by Country
9.1.2 Latin America C-X-C Chemokine Receptor Type 4 Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Type
9.3 Central & South America C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa C-X-C Chemokine Receptor Type 4 by Country
10.1.1 Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Country
10.1.2 Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Type
10.3 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Facts & Figures by Application

11 Company Profiles
11.1 AdAlta Pty Ltd.
11.1.1 AdAlta Pty Ltd. Corporation Information
11.1.2 AdAlta Pty Ltd. Description and Business Overview
11.1.3 AdAlta Pty Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
11.1.5 AdAlta Pty Ltd. Related Developments
11.2 Ambrx, Inc.
11.2.1 Ambrx, Inc. Corporation Information
11.2.2 Ambrx, Inc. Description and Business Overview
11.2.3 Ambrx, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
11.2.5 Ambrx, Inc. Related Developments
11.3 Anchor Therapeutics, Inc.
11.3.1 Anchor Therapeutics, Inc. Corporation Information
11.3.2 Anchor Therapeutics, Inc. Description and Business Overview
11.3.3 Anchor Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
11.3.5 Anchor Therapeutics, Inc. Related Developments
11.4 Biokine Therapeutics Ltd.
11.4.1 Biokine Therapeutics Ltd. Corporation Information
11.4.2 Biokine Therapeutics Ltd. Description and Business Overview
11.4.3 Biokine Therapeutics Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
11.4.5 Biokine Therapeutics Ltd. Related Developments
11.5 BioLineRx, Ltd.
11.5.1 BioLineRx, Ltd. Corporation Information
11.5.2 BioLineRx, Ltd. Description and Business Overview
11.5.3 BioLineRx, Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
11.5.5 BioLineRx, Ltd. Related Developments
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Corporation Information
11.6.2 Bristol-Myers Squibb Company Description and Business Overview
11.6.3 Bristol-Myers Squibb Company Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Products Offered
11.6.5 Bristol-Myers Squibb Company Related Developments
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Corporation Information
11.7.2 Eli Lilly and Company Description and Business Overview
11.7.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Products Offered
11.7.5 Eli Lilly and Company Related Developments
11.8 Globavir Biosciences, Inc.
11.8.1 Globavir Biosciences, Inc. Corporation Information
11.8.2 Globavir Biosciences, Inc. Description and Business Overview
11.8.3 Globavir Biosciences, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
11.8.5 Globavir Biosciences, Inc. Related Developments
11.9 GlycoMimetics, Inc.
11.9.1 GlycoMimetics, Inc. Corporation Information
11.9.2 GlycoMimetics, Inc. Description and Business Overview
11.9.3 GlycoMimetics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Products Offered
11.9.5 GlycoMimetics, Inc. Related Developments
11.10 NeED Pharma s.r.l.
11.10.1 NeED Pharma s.r.l. Corporation Information
11.10.2 NeED Pharma s.r.l. Description and Business Overview
11.10.3 NeED Pharma s.r.l. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Products Offered
11.10.5 NeED Pharma s.r.l. Related Developments
11.1 AdAlta Pty Ltd.
11.1.1 AdAlta Pty Ltd. Corporation Information
11.1.2 AdAlta Pty Ltd. Description and Business Overview
11.1.3 AdAlta Pty Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Products Offered
11.1.5 AdAlta Pty Ltd. Related Developments
11.12 Polyphor Ltd.
11.12.1 Polyphor Ltd. Corporation Information
11.12.2 Polyphor Ltd. Description and Business Overview
11.12.3 Polyphor Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Polyphor Ltd. Products Offered
11.12.5 Polyphor Ltd. Related Developments
11.13 Sanofi
11.13.1 Sanofi Corporation Information
11.13.2 Sanofi Description and Business Overview
11.13.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Sanofi Products Offered
11.13.5 Sanofi Related Developments
11.14 TaiGen Biotechnology Co., Ltd.
11.14.1 TaiGen Biotechnology Co., Ltd. Corporation Information
11.14.2 TaiGen Biotechnology Co., Ltd. Description and Business Overview
11.14.3 TaiGen Biotechnology Co., Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.14.4 TaiGen Biotechnology Co., Ltd. Products Offered
11.14.5 TaiGen Biotechnology Co., Ltd. Related Developments
11.15 Upsher-Smith Laboratories, Inc.
11.15.1 Upsher-Smith Laboratories, Inc. Corporation Information
11.15.2 Upsher-Smith Laboratories, Inc. Description and Business Overview
11.15.3 Upsher-Smith Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Upsher-Smith Laboratories, Inc. Products Offered
11.15.5 Upsher-Smith Laboratories, Inc. Related Developments
11.16 X4 Pharmaceuticals, Inc.
11.16.1 X4 Pharmaceuticals, Inc. Corporation Information
11.16.2 X4 Pharmaceuticals, Inc. Description and Business Overview
11.16.3 X4 Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.16.4 X4 Pharmaceuticals, Inc. Products Offered
11.16.5 X4 Pharmaceuticals, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 C-X-C Chemokine Receptor Type 4 Market Estimates and Projections by Region
12.1.1 Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Regions 2021-2026
12.1.2 Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Regions 2021-2026
12.2 North America C-X-C Chemokine Receptor Type 4 Market Size Forecast (2021-2026)
12.2.1 North America: C-X-C Chemokine Receptor Type 4 Sales Forecast (2021-2026)
12.2.2 North America: C-X-C Chemokine Receptor Type 4 Revenue Forecast (2021-2026)
12.2.3 North America: C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2021-2026)
12.3 Europe C-X-C Chemokine Receptor Type 4 Market Size Forecast (2021-2026)
12.3.1 Europe: C-X-C Chemokine Receptor Type 4 Sales Forecast (2021-2026)
12.3.2 Europe: C-X-C Chemokine Receptor Type 4 Revenue Forecast (2021-2026)
12.3.3 Europe: C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific C-X-C Chemokine Receptor Type 4 Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: C-X-C Chemokine Receptor Type 4 Sales Forecast (2021-2026)
12.4.2 Asia Pacific: C-X-C Chemokine Receptor Type 4 Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: C-X-C Chemokine Receptor Type 4 Market Size Forecast by Region (2021-2026)
12.5 Latin America C-X-C Chemokine Receptor Type 4 Market Size Forecast (2021-2026)
12.5.1 Latin America: C-X-C Chemokine Receptor Type 4 Sales Forecast (2021-2026)
12.5.2 Latin America: C-X-C Chemokine Receptor Type 4 Revenue Forecast (2021-2026)
12.5.3 Latin America: C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: C-X-C Chemokine Receptor Type 4 Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: C-X-C Chemokine Receptor Type 4 Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: C-X-C Chemokine Receptor Type 4 Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key C-X-C Chemokine Receptor Type 4 Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C-X-C Chemokine Receptor Type 4 Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. C-X-C Chemokine Receptor Type 4 Market Segments
Table 2. Ranking of Global Top C-X-C Chemokine Receptor Type 4 Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AM-3114
Table 5. Major Manufacturers of BL-8040
Table 6. Major Manufacturers of GMI-1359
Table 7. Major Manufacturers of HPH-112
Table 8. Major Manufacturers of Others
Table 9. Global C-X-C Chemokine Receptor Type 4 Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global C-X-C Chemokine Receptor Type 4 Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global C-X-C Chemokine Receptor Type 4 Sales by Regions 2015-2020 (K Pcs)
Table 12. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Regions (2015-2020)
Table 13. Global C-X-C Chemokine Receptor Type 4 Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global C-X-C Chemokine Receptor Type 4 Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global C-X-C Chemokine Receptor Type 4 Sales Share by Manufacturers (2015-2020)
Table 16. Global C-X-C Chemokine Receptor Type 4 Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global C-X-C Chemokine Receptor Type 4 by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in C-X-C Chemokine Receptor Type 4 as of 2019)
Table 18. C-X-C Chemokine Receptor Type 4 Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. C-X-C Chemokine Receptor Type 4 Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers C-X-C Chemokine Receptor Type 4 Price (2015-2020) (USD/Pcs)
Table 21. C-X-C Chemokine Receptor Type 4 Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers C-X-C Chemokine Receptor Type 4 Product Type
Table 23. Date of International Manufacturers Enter into C-X-C Chemokine Receptor Type 4 Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 26. Global C-X-C Chemokine Receptor Type 4 Sales Share by Type (2015-2020)
Table 27. Global C-X-C Chemokine Receptor Type 4 Revenue by Type (2015-2020) (US$ Million)
Table 28. Global C-X-C Chemokine Receptor Type 4 Revenue Share by Type (2015-2020)
Table 29. C-X-C Chemokine Receptor Type 4 Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 31. Global C-X-C Chemokine Receptor Type 4 Sales Share by Application (2015-2020)
Table 32. North America C-X-C Chemokine Receptor Type 4 Sales by Country (2015-2020) (K Pcs)
Table 33. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2015-2020)
Table 34. North America C-X-C Chemokine Receptor Type 4 Revenue by Country (2015-2020) (US$ Million)
Table 35. North America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2015-2020)
Table 36. North America C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 37. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Table 38. North America C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 39. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Table 40. Europe C-X-C Chemokine Receptor Type 4 Sales by Country (2015-2020) (K Pcs)
Table 41. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2015-2020)
Table 42. Europe C-X-C Chemokine Receptor Type 4 Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2015-2020)
Table 44. Europe C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 45. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Table 46. Europe C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 47. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Table 56. Latin America C-X-C Chemokine Receptor Type 4 Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa C-X-C Chemokine Receptor Type 4 Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2015-2020)
Table 60. Latin America C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Table 62. Latin America C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Table 72. AdAlta Pty Ltd. Corporation Information
Table 73. AdAlta Pty Ltd. Description and Major Businesses
Table 74. AdAlta Pty Ltd. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. AdAlta Pty Ltd. Product
Table 76. AdAlta Pty Ltd. Recent Development
Table 77. Ambrx, Inc. Corporation Information
Table 78. Ambrx, Inc. Description and Major Businesses
Table 79. Ambrx, Inc. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Ambrx, Inc. Product
Table 81. Ambrx, Inc. Recent Development
Table 82. Anchor Therapeutics, Inc. Corporation Information
Table 83. Anchor Therapeutics, Inc. Description and Major Businesses
Table 84. Anchor Therapeutics, Inc. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Anchor Therapeutics, Inc. Product
Table 86. Anchor Therapeutics, Inc. Recent Development
Table 87. Biokine Therapeutics Ltd. Corporation Information
Table 88. Biokine Therapeutics Ltd. Description and Major Businesses
Table 89. Biokine Therapeutics Ltd. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Biokine Therapeutics Ltd. Product
Table 91. Biokine Therapeutics Ltd. Recent Development
Table 92. BioLineRx, Ltd. Corporation Information
Table 93. BioLineRx, Ltd. Description and Major Businesses
Table 94. BioLineRx, Ltd. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. BioLineRx, Ltd. Product
Table 96. BioLineRx, Ltd. Recent Development
Table 97. Bristol-Myers Squibb Company Corporation Information
Table 98. Bristol-Myers Squibb Company Description and Major Businesses
Table 99. Bristol-Myers Squibb Company C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Bristol-Myers Squibb Company Product
Table 101. Bristol-Myers Squibb Company Recent Development
Table 102. Eli Lilly and Company Corporation Information
Table 103. Eli Lilly and Company Description and Major Businesses
Table 104. Eli Lilly and Company C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Eli Lilly and Company Product
Table 106. Eli Lilly and Company Recent Development
Table 107. Globavir Biosciences, Inc. Corporation Information
Table 108. Globavir Biosciences, Inc. Description and Major Businesses
Table 109. Globavir Biosciences, Inc. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. Globavir Biosciences, Inc. Product
Table 111. Globavir Biosciences, Inc. Recent Development
Table 112. GlycoMimetics, Inc. Corporation Information
Table 113. GlycoMimetics, Inc. Description and Major Businesses
Table 114. GlycoMimetics, Inc. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. GlycoMimetics, Inc. Product
Table 116. GlycoMimetics, Inc. Recent Development
Table 117. NeED Pharma s.r.l. Corporation Information
Table 118. NeED Pharma s.r.l. Description and Major Businesses
Table 119. NeED Pharma s.r.l. C-X-C Chemokine Receptor Type 4 Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. NeED Pharma s.r.l. Product
Table 121. NeED Pharma s.r.l. Recent Development
Table 122. Pharis Biotec GmbH Corporation Information
Table 123. Pharis Biotec GmbH Description and Major Businesses
Table 124. Pharis Biotec GmbH C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Pharis Biotec GmbH Product
Table 126. Pharis Biotec GmbH Recent Development
Table 127. Polyphor Ltd. Corporation Information
Table 128. Polyphor Ltd. Description and Major Businesses
Table 129. Polyphor Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. Polyphor Ltd. Product
Table 131. Polyphor Ltd. Recent Development
Table 132. Sanofi Corporation Information
Table 133. Sanofi Description and Major Businesses
Table 134. Sanofi C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Sanofi Product
Table 136. Sanofi Recent Development
Table 137. TaiGen Biotechnology Co., Ltd. Corporation Information
Table 138. TaiGen Biotechnology Co., Ltd. Description and Major Businesses
Table 139. TaiGen Biotechnology Co., Ltd. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. TaiGen Biotechnology Co., Ltd. Product
Table 141. TaiGen Biotechnology Co., Ltd. Recent Development
Table 142. Upsher-Smith Laboratories, Inc. Corporation Information
Table 143. Upsher-Smith Laboratories, Inc. Description and Major Businesses
Table 144. Upsher-Smith Laboratories, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. Upsher-Smith Laboratories, Inc. Product
Table 146. Upsher-Smith Laboratories, Inc. Recent Development
Table 147. X4 Pharmaceuticals, Inc. Corporation Information
Table 148. X4 Pharmaceuticals, Inc. Description and Major Businesses
Table 149. X4 Pharmaceuticals, Inc. C-X-C Chemokine Receptor Type 4 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. X4 Pharmaceuticals, Inc. Product
Table 151. X4 Pharmaceuticals, Inc. Recent Development
Table 152. Global C-X-C Chemokine Receptor Type 4 Sales Forecast by Regions (2021-2026) (K Pcs)
Table 153. Global C-X-C Chemokine Receptor Type 4 Sales Market Share Forecast by Regions (2021-2026)
Table 154. Global C-X-C Chemokine Receptor Type 4 Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 155. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share Forecast by Regions (2021-2026)
Table 156. North America: C-X-C Chemokine Receptor Type 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 157. North America: C-X-C Chemokine Receptor Type 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Europe: C-X-C Chemokine Receptor Type 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 159. Europe: C-X-C Chemokine Receptor Type 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 160. Asia Pacific: C-X-C Chemokine Receptor Type 4 Sales Forecast by Region (2021-2026) (K Pcs)
Table 161. Asia Pacific: C-X-C Chemokine Receptor Type 4 Revenue Forecast by Region (2021-2026) (US$ Million)
Table 162. Latin America: C-X-C Chemokine Receptor Type 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 163. Latin America: C-X-C Chemokine Receptor Type 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Middle East and Africa: C-X-C Chemokine Receptor Type 4 Sales Forecast by Country (2021-2026) (K Pcs)
Table 165. Middle East and Africa: C-X-C Chemokine Receptor Type 4 Revenue Forecast by Country (2021-2026) (US$ Million)
Table 166. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 167. Key Challenges
Table 168. Market Risks
Table 169. Main Points Interviewed from Key C-X-C Chemokine Receptor Type 4 Players
Table 170. C-X-C Chemokine Receptor Type 4 Customers List
Table 171. C-X-C Chemokine Receptor Type 4 Distributors List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. C-X-C Chemokine Receptor Type 4 Product Picture
Figure 2. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Type in 2020 & 2026
Figure 3. AM-3114 Product Picture
Figure 4. BL-8040 Product Picture
Figure 5. GMI-1359 Product Picture
Figure 6. HPH-112 Product Picture
Figure 7. Others Product Picture
Figure 8. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Application in 2020 & 2026
Figure 9. Liver Cancer
Figure 10. Myocardial Infarction
Figure 11. Renal Cell Carcinoma
Figure 12. Stroke
Figure 13. Others
Figure 14. C-X-C Chemokine Receptor Type 4 Report Years Considered
Figure 15. Global C-X-C Chemokine Receptor Type 4 Market Size 2015-2026 (US$ Million)
Figure 16. Global C-X-C Chemokine Receptor Type 4 Sales 2015-2026 (K Pcs)
Figure 17. Global C-X-C Chemokine Receptor Type 4 Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Region (2015-2020)
Figure 19. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Region in 2019
Figure 20. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region (2015-2020)
Figure 21. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region in 2019
Figure 22. Global C-X-C Chemokine Receptor Type 4 Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by C-X-C Chemokine Receptor Type 4 Revenue in 2019
Figure 24. C-X-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Type (2015-2020)
Figure 26. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Type in 2019
Figure 27. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type (2015-2020)
Figure 28. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Type in 2019
Figure 29. Global C-X-C Chemokine Receptor Type 4 Market Share by Price Range (2015-2020)
Figure 30. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Application (2015-2020)
Figure 31. Global C-X-C Chemokine Receptor Type 4 Sales Market Share by Application in 2019
Figure 32. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application (2015-2020)
Figure 33. Global C-X-C Chemokine Receptor Type 4 Revenue Market Share by Application in 2019
Figure 34. North America C-X-C Chemokine Receptor Type 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America C-X-C Chemokine Receptor Type 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country in 2019
Figure 37. North America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country in 2019
Figure 38. U.S. C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America C-X-C Chemokine Receptor Type 4 Market Share by Type in 2019
Figure 43. North America C-X-C Chemokine Receptor Type 4 Market Share by Application in 2019
Figure 44. Europe C-X-C Chemokine Receptor Type 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe C-X-C Chemokine Receptor Type 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe C-X-C Chemokine Receptor Type 4 Sales Market Share by Country in 2019
Figure 47. Europe C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country in 2019
Figure 48. Germany C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe C-X-C Chemokine Receptor Type 4 Market Share by Type in 2019
Figure 59. Europe C-X-C Chemokine Receptor Type 4 Market Share by Application in 2019
Figure 60. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Market Share by Region in 2019
Figure 63. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue Market Share by Region in 2019
Figure 64. China C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific C-X-C Chemokine Receptor Type 4 Market Share by Type in 2019
Figure 87. Asia Pacific C-X-C Chemokine Receptor Type 4 Market Share by Application in 2019
Figure 88. Latin America C-X-C Chemokine Receptor Type 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America C-X-C Chemokine Receptor Type 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America C-X-C Chemokine Receptor Type 4 Sales Market Share by Country in 2019
Figure 91. Latin America C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country in 2019
Figure 92. Mexico C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Type in 2019
Figure 99. Latin America C-X-C Chemokine Receptor Type 4 Market Share by Application in 2019
Figure 100. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Market Share by Country in 2019
Figure 103. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Market Share by Country in 2019
Figure 104. Turkey C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E C-X-C Chemokine Receptor Type 4 Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E C-X-C Chemokine Receptor Type 4 Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Share by Type in 2019
Figure 111. Middle East and Africa C-X-C Chemokine Receptor Type 4 Market Share by Application in 2019
Figure 112. North America C-X-C Chemokine Receptor Type 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America C-X-C Chemokine Receptor Type 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe C-X-C Chemokine Receptor Type 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe C-X-C Chemokine Receptor Type 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific C-X-C Chemokine Receptor Type 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific C-X-C Chemokine Receptor Type 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America C-X-C Chemokine Receptor Type 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America C-X-C Chemokine Receptor Type 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa C-X-C Chemokine Receptor Type 4 Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa C-X-C Chemokine Receptor Type 4 Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のC-X-Cケモカイン受容体タイプ4市場2026:インサイト・予測] (Global C-X-C Chemokine Receptor Type 4 Market Insights and Forecast to 2026 / QYR20NV00812)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆